Search Results - "Fernández Abad, M" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial

Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial

by Vaz Batista, M., Pérez-García, J.M., Cortez, P., Garrigós, L., Fernández-Abad, M., Gion, M., Martínez-Bueno, A., Saavedra, C., Teruel, I., Fernandez-Ortega, A., Servitja, S., Ruiz-Borrego, M., de la Haba-Rodríguez, J., Martrat, G., Pérez-Escuredo, J., Alcalá-López, D., Sampayo-Cordero, M., Braga, S., Cortés, J., Llombart-Cussac, A.
Published in ESMO open (01.09.2024)

Get full text

Journal Article

Expression of gut‐homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV‐1‐infected patients?

Expression of gut‐homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV‐1‐infected patients?

by Abad‐Fernández, M, Gutiérrez, C, Madrid, N, Hernández‐Novoa, B, Díaz, L, Muñoz‐Fernández, MA, Moreno, S, Vallejo, A
Published in HIV medicine (01.01.2015)

Get full text

Journal Article

Visceral leishmaniasis as an independent cause of high immune activation, T‐cell senescence, and lack of immune recovery in virologically suppressed HIV‐1‐coinfected patients

Visceral leishmaniasis as an independent cause of high immune activation, T‐cell senescence, and lack of immune recovery in virologically suppressed HIV‐1‐coinfected patients

by Casado, JL, Abad‐Fernández, M, Moreno, S, Pérez‐Elías, MJ, Moreno, A, Bernardino, JI, Vallejo, A
Published in HIV medicine (01.04.2015)

Get full text

Journal Article

Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study

Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study

by Guerrero-Zotano, Á., Pérez-García, J.M., Ruiz-Borrego, M., Bermejo, B., Gil-Gil, M., de la Haba, J., Alba Conejo, E., Quiroga, V., Carañana, V., Urruticoechea, A., Morales, S., Bellet, M., Antón, A., Fernández-Abad, M., Sánchez-Rovira, P., Calabuig, L., Pérez-Escuredo, J., Sampayo-Cordero, M., Cortés, J., Llombart-Cussac, A.
Published in ESMO open (01.10.2024)

Get full text

Journal Article

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer

by Guarneri, V, Fasching, P A, Fernández Abad, M, García-Saenz, J A, Schneeweiss, A, Colleoni, M, Petru, E, Costigan, T M, Caldwell, C W, Barriga, S, Hurvitz, S, Slamon, D
Published in Annals of oncology (01.10.2017)

Get full text

Journal Article

High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis

High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis

by Vallejo, A., Abad-Fernández, M., Moreno, S., Moreno, A., Pérez-Elías, M. J., Dronda, F., Casado, J. L.
Published in European journal of clinical microbiology & infectious diseases (01.02.2015)

Get full text

Journal Article

P200 Neoadjuvant therapy in HER2+ breast cancer: Opti-HER Heart run-in phase safety data (SOLTI-1002)

P200 Neoadjuvant therapy in HER2+ breast cancer: Opti-HER Heart run-in phase safety data (SOLTI-1002)

by Gavilá, J, Fernández-Abad, M, Pérez, J.M, Guerrero, Á.L, Oliveira, M, Llobet-Canela, M, Llombart, A
Published in Breast (Edinburgh) (01.03.2015)

Get full text

Journal Article

Efficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience

Efficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience

by Martin Huertas, R., Lopez Miranda, E., Corral de la Fuente, E., Serrano Domingo, J.J., Fernandez Abad, M., Martinez, N., Guerra, E.M., Cortes Salgado, A., Gion Cortes, M., Carrato Mena, A.
Published in Annals of oncology (01.05.2019)

Get full text

Journal Article

121P Impact of HER2 low (H2L) expression on prognosis in luminal locally advanced or metastatic breast cancer (BC): A retrospective study

121P Impact of HER2 low (H2L) expression on prognosis in luminal locally advanced or metastatic breast cancer (BC): A retrospective study

by Saavedra Serrano, C., Pérez Mies, B., Gion Cortes, M., Cortes Salgado, A., Fernández Abad, M., Martinez-Jañez, N., Soriano, M., Guerra, E.M., Miranda, E. Lopez
Published in Annals of oncology (01.05.2021)

Get full text

Journal Article

Expression of gut-homing beta 7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?

Expression of gut-homing beta 7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?

by Abad-Fernandez, M, Gutierrez, C, Madrid, N, Hernandez-Novoa, B, Diaz, L, Munoz-Fernandez, MA, Moreno, S, Vallejo, A
Published in HIV medicine (01.01.2015)

Get full text

Journal Article

330TiP Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH

330TiP Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH

by Vaz Batista, M., Pérez-Garcia, J.M., Llombart Cussac, A., Cortez, P., Ruiz Borrego, M., De La Haba, J., Cejalvo, J.M., Racca, F., Servitja, S., Blanch, S., Lema, L., Galàn Garmaje, M., Fernández-Abad, M., Fernández, A., Iranzo, V., González-Santiago, S., Gion, M., Nave, M., Cortés, J., Braga, S.
Published in Annals of oncology (01.09.2021)

Get full text

Journal Article

EP-1200: Partial breast irradiation and stereotactic body radiation therapy with Exactrac in breast cancer patients

EP-1200: Partial breast irradiation and stereotactic body radiation therapy with Exactrac in breast cancer patients

by Ciervide, R, Valero Albarrán, J, Garcia-Aranda, M, Lopéz Gonzalez, M, García, J.U.A.N, Sanchez Augar, E, Hernando Requejo, O, Calvo, I, Fernandez Abad, M, Rubio, M
Published in Radiotherapy and oncology (2014)

Get full text

Journal Article

384TiP - Effectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

384TiP - Effectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

by Alés-Martínez, J.E., Morales, S., Fernández Abad, M., Sánchez-Rovira, P., Salvador Bofill, F.J., Lahuerta, A., García-Sáenz, J.A., Garau Llinas, I., Díaz Redondo, T., Ferrer, N., Carañana, V., López, R., Alonso Soler, S.E., Bermejo, B., de la Haba, J., Zamora, P., Balmana, J., López-Miranda, E., Cortés, J., Llombart Cussac, A.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

384TiPEffectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

384TiPEffectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

by Alés-Martínez, J E, Morales, S, Fernández Abad, M, Sánchez-Rovira, P, Salvador Bofill, F J, Lahuerta, A, García-Sáenz, J A, Garau Llinas, I, Díaz Redondo, T, Ferrer, N, Carañana, V, López, R, Alonso Soler, S E, Bermejo, B, de la Haba, J, Zamora, P, Balmana, J, López-Miranda, E, Cortés, J, Llombart Cussac, A
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Effectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

Effectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

by Alés-Martínez, J.E., Morales, S., Fernández Abad, M., Sánchez-Rovira, P., Salvador Bofill, F.J., Lahuerta, A., García-Sáenz, J.A., Garau Llinas, I., Díaz Redondo, T., Ferrer, N., Carañana, V., López, R., Alonso Soler, S.E., Bermejo, B., de la Haba, J., Zamora, P., Balmana, J., López-Miranda, E., Cortés, J., Llombart Cussac, A.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer

Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer

by Hurvitz, S, Martin, M, Fernández Abad, M, Chan, D, Rostorfer, R, Petru, E, Barriga, S, Costigan, TM, Caldwell, CW, Nguyen, T, Press, M, Slamon, D
Published in Cancer research (Chicago, Ill.) (15.02.2017)

Get full text

Journal Article

High levels of CD4^sup +^ CTLA-4^sup +^ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis

High levels of CD4^sup +^ CTLA-4^sup +^ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis

by Vallejo, A, Abad-fernández, M, Moreno, S, Moreno, A, Pérez-elías, M J, Dronda, F, Casado, J L
Published in European journal of clinical microbiology & infectious diseases (01.02.2015)

Get full text

Journal Article

Abstract P1-01-12: Comparison of local clinical subtyping to central molecular classification using microarray-based expression test in breast cancer patients

Abstract P1-01-12: Comparison of local clinical subtyping to central molecular classification using microarray-based expression test in breast cancer patients

by Fernández-Abad, M, Cortés-Salgado, A, Martínez-Jáñez, N, Cortez-Castedo, P, Muñoz-Del Toro, J, López-Miranda, E, Guerra-Alia, EM, Gión-Cortés, M, Reguera-Puertas, P, Martínez-Saez, O, Molina-Cerrillo, J, Villamayor, M, Roberts-Cervantes, E, Gómez-Rueda, A, Carrato-Mena, A
Published in Cancer research (Chicago, Ill.) (15.02.2016)

Get full text

Journal Article

188PEfficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience

188PEfficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience

by Martin Huertas, R, Lopez Miranda, E, Corral de la Fuente, E, Serrano Domingo, J J, Fernandez Abad, M, Martinez, N, Guerra, E M, Cortes Salgado, A, Gion Cortes, M, Carrato Mena, A
Published in Annals of oncology (01.05.2019)

Get full text

Journal Article

The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients

The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients

by VALLEJO, Alejandro, GUTIERREZ, Carolina, MUNOZ-FERNANDEZ, María A, MORENO, Santiago, HERNANDEZ-NOVOA, Beatriz, DIAZ, Laura, MADRID, Nadia, ABAD-FERNANDEZ, María, DRONDA, Fernando, PEREZ-ELIAS, Maria J, ZAMORA, Javier, MUNOZ, Eduardo
Published in AIDS (London) (24.09.2012)

Get full text

Journal Article